Benzinga | Aug 5, 2020 04:59PM EDT

ORIC Pharmaceuticals Q2 EPS $(0.51) Misses $(0.40) Estimate

ORIC Pharmaceuticals (NASDAQ:ORIC) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0.40) by 27.5 percent. This is a 84.01 percent increase over losses of $(3.19) per share from the same period last year.